Unknown

Dataset Information

Intense pulsed-light treatment improves objective optical quality in patients with meibomian gland dysfunction.


ABSTRACT:

Background

To evaluate changes in objective optical quality following intense pulsed light (IPL) treatment combined with meibomian gland (MG) expression (MGX) in patients with MG dysfunction (MGD).

Methods

This retrospective cross-sectional study included MGD-related dry eye disease (DED) patients who received IPL treatment between March and December 2021 at Kim's Eye Hospital, Seoul, Republic of Korea. Each patient underwent four sessions of IPL treatment using Lumenis M22 (Lumenis Ltd., Yokneam, Israel) and MGX at three-week intervals.

Results

This study included 90 eyes from 45 patients with MGD. The mean age was 52.3 ± 16.1 years (range, 20-75 years), and 53.3% (24/45) of patients were female. Compared with the baseline, all clinical symptoms and signs significant

SUBMITTER: Whang WJ 

PROVIDER: S-EPMC10148435 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature